Cargando…

Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine

Detalles Bibliográficos
Autores principales: Pijpers, Judith A, Ferrari, Michel D, Terwindt, Gisela M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261126/
https://www.ncbi.nlm.nih.gov/pubmed/31782777
http://dx.doi.org/10.1093/brain/awz368
_version_ 1783540450328576000
author Pijpers, Judith A
Ferrari, Michel D
Terwindt, Gisela M
author_facet Pijpers, Judith A
Ferrari, Michel D
Terwindt, Gisela M
author_sort Pijpers, Judith A
collection PubMed
description
format Online
Article
Text
id pubmed-7261126
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72611262020-06-03 Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine Pijpers, Judith A Ferrari, Michel D Terwindt, Gisela M Brain Letters to the Editor Oxford University Press 2020-01 2019-11-29 /pmc/articles/PMC7261126/ /pubmed/31782777 http://dx.doi.org/10.1093/brain/awz368 Text en © The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letters to the Editor
Pijpers, Judith A
Ferrari, Michel D
Terwindt, Gisela M
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
title Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
title_full Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
title_fullStr Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
title_full_unstemmed Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
title_short Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
title_sort reply: onabotulinumtoxina should be considered in medication overuse withdrawal in patients with chronic migraine
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261126/
https://www.ncbi.nlm.nih.gov/pubmed/31782777
http://dx.doi.org/10.1093/brain/awz368
work_keys_str_mv AT pijpersjuditha replyonabotulinumtoxinashouldbeconsideredinmedicationoverusewithdrawalinpatientswithchronicmigraine
AT ferrarimicheld replyonabotulinumtoxinashouldbeconsideredinmedicationoverusewithdrawalinpatientswithchronicmigraine
AT terwindtgiselam replyonabotulinumtoxinashouldbeconsideredinmedicationoverusewithdrawalinpatientswithchronicmigraine